News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,914 Results
Type
Article (8176)
Company Profile (140)
Press Release (476597)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (166949)
Career Advice (305)
Deals (25782)
Drug Delivery (7)
Drug Development (53032)
Employer Resources (14)
FDA (9789)
Job Trends (8594)
News (238581)
Policy (17935)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33225)
ALS (104)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (279)
Approvals (10398)
Artificial intelligence (323)
ASCO (162)
Autoimmune disease (206)
Automation (28)
Bankruptcy (262)
Best Places to Work (6978)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (506)
Cancer (3662)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (37)
Clinical research (47971)
Collaboration (1238)
Commercialization (2)
Compensation (1448)
Complete response letters (34)
COVID-19 (759)
CRISPR (63)
C-suite (736)
Cystic fibrosis (85)
Data (5613)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (340)
Diagnostics (4174)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73568)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87661)
Executive appointments (699)
FDA (12394)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (907)
Gene editing (125)
Generative AI (11)
Gene therapy (317)
GLP-1 (293)
Government (946)
Grass and pollen (2)
Guidances (282)
Healthcare (9321)
Hematology (97)
HIV (52)
Huntington's disease (23)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (57)
Indications (155)
Infectious disease (947)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (250)
Interviews (41)
IPO (12405)
IRA (2)
Job creations (1973)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Labor market (1)
Layoffs (60)
Legal (5201)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (267)
Machine learning (27)
Management (3)
Manufacturing (524)
Marketing (7)
MASH (117)
Medical device (8650)
Medtech (8788)
Mergers & acquisitions (14408)
Metabolic disorders (703)
mRNA (57)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (221)
Neuropsychiatric disorders (38)
Neuroscience (1816)
NextGen: Class of 2026 (3152)
Non-profit (842)
Obesity (223)
Opinion (13)
Ovarian cancer (162)
Pain (170)
Pancreatic cancer (194)
Parkinson's disease (200)
Partnered (11)
Patents (466)
Patient recruitment (498)
Peanut (31)
People (41237)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15495)
Phase 2 (21435)
Phase 3 (14443)
Pipeline (7068)
Policy (18)
Postmarket research (1572)
Preclinical (6544)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (570)
Real estate (3022)
Recruiting (6)
Regulatory (14814)
Reports (18)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (153)
Series B (119)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2023)
Stomach cancer (3)
Supply chain (50)
Tariffs (1)
The Weekly (2)
Vaccines (319)
Venture capital (20)
Weight loss (75)
Women's health (78)
Date
Today (96)
Last 7 days (533)
Last 30 days (1530)
Last 365 days (19232)
2026 (11789)
2025 (19322)
2024 (23047)
2023 (26582)
2022 (34660)
2021 (37210)
2020 (33533)
2019 (23295)
2018 (17487)
2017 (18780)
2016 (17933)
2015 (24277)
2014 (21714)
2013 (18166)
2012 (20243)
2011 (20451)
2010 (20353)
Location
Africa (227)
Alabama (72)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (17891)
Australia (2100)
California (11805)
Canada (3104)
China (514)
Colorado (479)
Connecticut (403)
Delaware (206)
Europe (25161)
Florida (1764)
Georgia (371)
Hawaii (3)
Idaho (46)
Illinois (694)
India (46)
Indiana (314)
Iowa (14)
Japan (395)
Kansas (99)
Kentucky (30)
Louisiana (26)
Maine (25)
Maryland (1181)
Massachusetts (7779)
Michigan (305)
Minnesota (558)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (113)
New Hampshire (60)
New Jersey (2596)
New Mexico (12)
New York (2792)
North Carolina (1256)
North Dakota (4)
Northern California (5901)
Ohio (273)
Oklahoma (14)
Oregon (16)
Pennsylvania (2233)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4902)
Tennessee (119)
Texas (1903)
United States (38395)
Utah (357)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (912)
West Virginia (1)
Wisconsin (73)
484,914 Results for "genmab inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
Rina-S is the last candidate standing from Genmab’s $1.8 billion ProfoundBio acquisition two years ago, with the Danish drugmaker ending development of another clinical program stemming from the buyout.
May 15, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Genmab Announces Financial Results for the First Half of 2026
August 6, 2026
·
8 min read
Press Releases
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
July 15, 2026
·
3 min read
Press Releases
Grant of Restricted Stock Units and Warrants to Employees in Genmab - June 11, 2026
June 11, 2026
·
4 min read
Press Releases
Genmab A/S Share Capital Reduction
April 19, 2026
·
3 min read
Press Releases
Genmab Announces Financial Results for the First Quarter of 2026
May 7, 2026
·
6 min read
Press Releases
Genmab Publishes 2025 Annual Report
February 17, 2026
·
9 min read
Press Releases
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
April 14, 2026
·
3 min read
Press Releases
Genmab Portfolio Prioritization Update
December 29, 2025
·
4 min read
Press Releases
Genmab to Participate in Upcoming March 2026 Investor Conferences
February 26, 2026
·
3 min read
1 of 48,492
Next
